These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 1725942)

  • 21. Finasteride for benign prostatic hyperplasia.
    Geller DM
    N Engl J Med; 1993 Feb; 328(6):442-3. PubMed ID: 7678437
    [No Abstract]   [Full Text] [Related]  

  • 22. Optimising the medical management of benign prostatic hyperplasia.
    McDermott T
    Br J Clin Pract; 1997 Mar; 51(2):116-8. PubMed ID: 9158256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hormonal therapy for benign prostatic hyperplasia].
    Sakai H; Kanetake H
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():358-61. PubMed ID: 12599600
    [No Abstract]   [Full Text] [Related]  

  • 24. Selecting therapy for maintaining sexual function in patients with benign prostatic hyperplasia.
    Nehra A
    BJU Int; 2005 Aug; 96(3):237-43. PubMed ID: 16042709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Finasteride for benign prostatic hyperplasia.
    DuBeau CE
    N Engl J Med; 1993 Feb; 328(6):443. PubMed ID: 7678439
    [No Abstract]   [Full Text] [Related]  

  • 26. Medical management of benign prostatic hypertrophy.
    Geller J
    Compr Ther; 1994; 20(12):682-7. PubMed ID: 7533690
    [No Abstract]   [Full Text] [Related]  

  • 27. Finasteride: the first 5 alpha-reductase inhibitor.
    Sudduth SL; Koronkowski MJ
    Pharmacotherapy; 1993; 13(4):309-25; discussion 325-9. PubMed ID: 7689728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A trial of the use of finasteride and terazosin in patients with benign prostatic hyperplasia].
    Pushkar' DIu; Kosko DV; Loran OB; Kan IaD; Sapozhnikov IM; Tevlin KP
    Urol Nefrol (Mosk); 1995; (4):32-5. PubMed ID: 7571199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current drug therapy of benign prostatic hyperplasia].
    Schmidbauer CP; Madersbacher S
    Wien Med Wochenschr; 1996; 146(8):161-4. PubMed ID: 8767400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [5-alpha reductase inhibitors or alpha blockers? The combination brakes best prostatic hyperplasia].
    MMW Fortschr Med; 2002 Oct; 144(44):56. PubMed ID: 12494605
    [No Abstract]   [Full Text] [Related]  

  • 31. [Benign prostatic hyperplasia: medical therapy].
    Schlenker B; Gratzke C; Weidlich P; Seitz M; Reich O; Stief CG
    MMW Fortschr Med; 2007 Aug; 149(33-34):29-31; quiz 32. PubMed ID: 17912863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Non surgical treatment of benign prostatic hypertrophy].
    Martini E; Vaggi L; Rucci A; Di Clemente L
    J Urol (Paris); 1993; 99(6):278-82. PubMed ID: 7516366
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative analysis of alpha-blocker utilization in combination with 5-alpha reductase inhibitors for enlarged prostate in a managed care setting among Medicare-aged men.
    Issa MM; Lin PJ; Eaddy MT; Shah MB; Davis EA
    Am J Manag Care; 2008 May; 14(5 Suppl 2):S160-6. PubMed ID: 18611090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacotherapy in benign prostatic hyperplasia].
    Hauri D
    Ther Umsch; 1995 Jun; 52(6):378-82. PubMed ID: 7541566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical management of benign prostatic hyperplasia.
    Gray M; Allensworth D
    Urol Nurs; 1997 Dec; 17(4):137-41. PubMed ID: 9451241
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapeutic controversies: clinical treatment of benign prostatic hyperplasia.
    Geller J; Kirchenbaum A; Lepor H; Levine AC
    J Clin Endocrinol Metab; 1995 Mar; 80(3):745-7. PubMed ID: 7533770
    [No Abstract]   [Full Text] [Related]  

  • 37. Promise for prostatitis?
    Wyllie MG
    BJU Int; 2005 Nov; 96(7):1137-8. PubMed ID: 16225543
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment options in benign prostatic hypertrophy.
    Stone NN
    Hosp Pract (Off Ed); 1992 Oct; 27(10A):85-8, 91-2. PubMed ID: 1383248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical treatment of benign prostatic hyperplasia: 5 alpha-reductase inhibitors and alpha-adrenergic antagonists.
    Monda JM; Oesterling JE
    Mayo Clin Proc; 1993 Jul; 68(7):670-9. PubMed ID: 7688840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Finasteride for benign prostatic hyperplasia.
    Holdcroft C
    Nurse Pract; 1993 Mar; 18(3):57-8. PubMed ID: 7681553
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.